This overview is educational, not medical advice, so anyone considering a peptide regimen, prescription or non-prescription, should consult a licensed healthcare provider to confirm it's appropriate for their health history
In particular, retatrutide, a triple agonist targeting GLP-1 receptors, GIP, and glucagon receptors, has demonstrated substantial metabolic benefits, raising interest in its potential for treating substance use disorders as well (Jastreboff et al
All product reviews and testimonials are the sole opinions, findings, or experiences of our customers and not those of our staff
3 Both results significantly exceeded those achieved in clinical trials with medication alone, suggesting that appropriate support may enhance outcomes
It functions to help regulate glucose levels in a manner similar to the GLP-1 hormone that your stomach naturally releases after eating
The clinical results of both GLP-1 drugs, especially tirzepatide, are impressive